Tango Therapeutics, Inc.
TNGX
$1.29
$0.010.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 257.92M | 293.28M | 322.11M | 343.60M | 336.89M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.43M | 7.54M | 6.30M | 8.44M | 8.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 856.00K |
| Total Current Assets | 266.34M | 300.82M | 328.41M | 352.04M | 346.54M |
|
|
|||||
| Total Current Assets | 266.34M | 300.82M | 328.41M | 352.04M | 346.54M |
| Net Property, Plant & Equipment | 47.58M | 49.02M | 50.47M | 51.61M | 53.42M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.57M | 2.58M | 2.58M | 2.58M | 2.61M |
| Total Assets | 316.49M | 352.42M | 381.45M | 406.22M | 402.57M |
|
|
|||||
| Total Accounts Payable | 1.60M | 4.11M | 1.06M | 3.90M | 2.79M |
| Total Accrued Expenses | 14.76M | 12.26M | 15.26M | 11.77M | 14.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.45M | 2.86M | 2.36M | 2.07M | 2.08M |
| Total Finance Division Other Current Liabilities | 19.35M | 18.35M | 25.18M | 25.06M | 26.96M |
| Total Other Current Liabilities | 19.35M | 18.35M | 25.18M | 25.06M | 26.96M |
| Total Current Liabilities | 38.17M | 37.58M | 43.87M | 42.79M | 45.94M |
|
|
|||||
| Total Current Liabilities | 38.17M | 37.58M | 43.87M | 42.79M | 45.94M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 34.04M | 34.76M | 35.47M | 36.17M | 36.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 44.77M | 50.90M | 54.44M | 62.81M | 66.68M |
| Total Liabilities | 116.98M | 123.25M | 133.78M | 141.77M | 149.46M |
|
|
|||||
| Common Stock & APIC | 700.74M | 692.31M | 682.73M | 673.88M | 624.18M |
| Retained Earnings | -501.56M | -463.89M | -434.72M | -409.17M | -371.26M |
| Treasury Stock & Other | 336.00K | 750.00K | -334.00K | -257.00K | 186.00K |
| Total Common Equity | 199.52M | 229.17M | 247.67M | 264.45M | 253.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 199.52M | 229.17M | 247.67M | 264.45M | 253.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 199.52M | 229.17M | 247.67M | 264.45M | 253.11M |
|
|
|||||